Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
J Allergy Clin Immunol
; 133(3): 921-3, 2014 Mar.
Article
in En
| MEDLINE
| ID: mdl-24418480
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Eosinophilia
/
Asthma
/
Interleukin-5
/
Antibodies, Monoclonal, Humanized
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2014
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States